• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Uptake kinetics of monoclonal antibodies by human malignant melanoma multicell spheroids.

作者信息

Kwok C S, Cole S E, Liao S K

机构信息

Hamilton Regional Centre, Ontario Cancer Foundation, Ontario, Canada.

出版信息

Cancer Res. 1988 Apr 1;48(7):1856-63.

PMID:3349464
Abstract

Detailed uptake kinetics by multicell spheroids of three tumor associated monoclonal antibodies was investigated. The spheroids were established from a human melanoma cell line and the human colon adenocarcinoma cell line HT29 as in vitro models of poorly vascularized micrometastases in vivo. The selected antibodies 96.5, 140.240, and OST15 showed a wide range of reactivity against the melanoma cell but they all had negligible binding with the colon cancer cell. Uptake of the antibodies by small spheroids (about 300 micron diameter) was generally sigmoidal in shape with respect to incubation time, and amount of uptake followed the same trend of immunoreactivity of the antibodies with single cells. The correlation was weaker for spheroids with diameter greater than 500 micron presumably due to the increasing size of the necrotic core. By varying the concentration of the antibodies in the incubation medium from tracer dose (0.2 microgram/ml) to a higher dose (3 micrograms/ml), negligible changes in the amount of antibodies bound with their target spheroids were observed. Nonspecific binding between antibodies and spheroids, however, resulted in proportional increase in uptake.

摘要

相似文献

1
Uptake kinetics of monoclonal antibodies by human malignant melanoma multicell spheroids.
Cancer Res. 1988 Apr 1;48(7):1856-63.
2
Optimization of radioimmunotherapy using human malignant melanoma multicell spheroids as a model.以人恶性黑色素瘤多细胞球体为模型的放射免疫疗法优化
Cancer Res. 1989 Jun 15;49(12):3276-81.
3
Mathematical model of simultaneous diffusion and binding of antitumor antibodies in multicellular human tumor spheroids.多细胞人肿瘤球体中抗肿瘤抗体同时扩散与结合的数学模型
Cancer Res. 1988 Jul 15;48(14):4032-7.
4
Comparisons between two monoclonal antibodies that bind to the same antigen but have differing affinities: uptake kinetics and 125I-antibody therapy efficacy in multicell spheroids.两种与相同抗原结合但亲和力不同的单克隆抗体之间的比较:多细胞球体中的摄取动力学和¹²⁵I抗体治疗效果
Cancer Res. 1992 Sep 1;52(17):4728-34.
5
Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.放射性标记的抗癌胚抗原单克隆抗体及其抗原结合片段在人结肠多细胞肿瘤球体中的穿透与结合
Cancer Res. 1987 Mar 15;47(6):1627-33.
6
Uptake, penetration, and binding of monoclonal antibodies with increasing affinity in human osteosarcoma multicell spheroids.
Anticancer Res. 1998 Sep-Oct;18(5A):3153-61.
7
Diffusion and binding of monoclonal antibody TNT-1 in multicellular tumor spheroids.单克隆抗体TNT-1在多细胞肿瘤球体中的扩散与结合
J Natl Cancer Inst. 1991 Feb 6;83(3):200-4. doi: 10.1093/jnci/83.3.200.
8
131I-anticarcinoembryonic antigen therapy of LS174T human colon adenocarcinoma spheroids.
Cancer Res. 1989 Jun 15;49(12):3401-6.
9
Uptake and release of radiolabelled monoclonal antibody Po66 by multicellular aggregates obtained from a lung squamous carcinoma cell line.
Anticancer Res. 1993 Mar-Apr;13(2):451-7.
10
Oxygenation and differentiation in multicellular spheroids of human colon carcinoma.人结肠癌多细胞球体中的氧合作用与分化
Cancer Res. 1986 Oct;46(10):5320-9.

引用本文的文献

1
A multiparametric analysis including single-cell and subcellular feature assessment reveals differential behavior of spheroid cultures on distinct ultra-low attachment plate types.一项包括单细胞和亚细胞特征评估的多参数分析揭示了在不同的超低附着板类型上球体培养物的差异行为。
Front Bioeng Biotechnol. 2024 Aug 2;12:1422235. doi: 10.3389/fbioe.2024.1422235. eCollection 2024.
2
Analysis of the Equilibrium Phase in Immune-Controlled Tumors Provides Hints for Designing Better Strategies for Cancer Treatment.免疫控制肿瘤平衡期的分析为设计更好的癌症治疗策略提供了线索。
Front Oncol. 2022 Jun 27;12:878827. doi: 10.3389/fonc.2022.878827. eCollection 2022.
3
Complement-mediated killing of microtumors in vitro.
补体介导的体外微小肿瘤杀伤作用。
Am J Pathol. 1998 Sep;153(3):845-55. doi: 10.1016/S0002-9440(10)65626-X.
4
Diffusion of an anti-transferrin receptor antibody in cultured murine melanoma cell layers.抗转铁蛋白受体抗体在培养的小鼠黑色素瘤细胞层中的扩散。
Pharm Res. 1995 Dec;12(12):1907-16. doi: 10.1023/a:1016424321378.
5
The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodies.使用人肿瘤球体模型比较1簇和w4簇抗体的摄取情况,以选择用于小细胞肺癌(SCLC)靶向治疗的抗体。
Br J Cancer. 1994 Feb;69(2):247-52. doi: 10.1038/bjc.1994.47.
6
Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin.单个多细胞肿瘤球体对免疫毒素和蓖麻毒素的异质性反应。
Br J Cancer. 1995 Sep;72(3):607-14. doi: 10.1038/bjc.1995.381.
7
Targeting cancer micrometastases with monoclonal antibodies: a binding-site barrier.用单克隆抗体靶向癌症微转移灶:结合位点障碍
Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8999-9003. doi: 10.1073/pnas.92.19.8999.
8
Homogeneous penetration but heterogeneous binding of antibodies to carcinoembryonic antigen in human colon carcinoma HT-29 spheroids.抗体在人结肠癌HT - 29球体中对癌胚抗原的穿透均匀但结合不均一。
Cancer Immunol Immunother. 1989;30(5):269-76. doi: 10.1007/BF01744893.
9
Quantification of transport and binding parameters using fluorescence recovery after photobleaching. Potential for in vivo applications.使用光漂白后荧光恢复技术对转运和结合参数进行定量分析。体内应用的潜力。
Biophys J. 1990 Oct;58(4):873-85. doi: 10.1016/S0006-3495(90)82432-2.
10
Antibody mediated targeting of radioisotopes, drugs and toxins in diagnosis and treatment.抗体介导的放射性同位素、药物和毒素在诊断与治疗中的靶向作用。
Indian J Pediatr. 1990 Jan-Feb;57(1):29-46. doi: 10.1007/BF02722127.